Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Bloom Energy
BE
$62.1B
| $7.15M | ﹤0.01% |
363,585
+28,014
| +8% | +$669K |
|
|
CHX
3002
DELISTED
ChampionX
CHX
| $7.15M | ﹤0.01% |
239,833
+33,662
| +16% | +$983K |
|
3003
CALL
AppFolio
APPF
$8.3B
| $7.15M | ﹤0.01% |
32,500
+600
| +2% | +$138K |
|
3004
Allstate
ALL
$65.9B
| $7.14M | ﹤0.01% |
34,503
-89,788
| -72% | -$17.5M |
|
3005
TE Connectivity
TEL
$58.7B
| $7.13M | ﹤0.01% |
50,435
-210,628
| -81% | -$31.2M |
|
3006
PUT
Symbotic
SYM
$5.18B
| $7.12M | ﹤0.01% |
352,200
-464,600
| -57% | -$11.9M |
|
3007
PUT
Ameriprise Financial
AMP
$49.4B
| $7.12M | ﹤0.01% |
14,700
+4,200
| +40% | +$2.2M |
|
3008
PUT
CoreCivic
CXW
$3.34B
| $7.11M | ﹤0.01% |
350,300
-20,200
| -5% | -$406K |
|
3009
Autodesk
ADSK
$55B
| $7.11M | ﹤0.01% |
27,146
-61,874
| -70% | -$17.6M |
|
3010
Cardinal Health
CAH
$54.6B
| $7.1M | ﹤0.01% |
51,569
-197,458
| -79% | -$25.2M |
|
3011
Freedom Holding
FRHC
$11.2B
| $7.1M | ﹤0.01% |
53,752
+50,122
| +1,381% | +$7M |
|
3012
PUT
Hormel Foods
HRL
$11.9B
| $7.1M | ﹤0.01% |
229,500
+37,300
| +19% | +$1.11M |
|
3013
PUT
First Majestic Silver
AG
$10.2B
| $7.1M | ﹤0.01% |
1,061,100
-84,400
| -7% | -$503K |
|
3014
Delcath Systems
DCTH
$567M
| $7.1M | ﹤0.01% |
557,400
+138,791
| +33% | +$1.97M |
|
|
JBTM
3015
JBT Marel
JBTM
$6.14B
| $7.09M | ﹤0.01% |
58,029
-74,228
| -56% | -$9.4M |
|
3016
iShares Russell 2500 ETF
SMMD
$3.78B
| $7.09M | ﹤0.01% |
113,365
+104,652
| +1,201% | +$7.05M |
|
3017
BlackBerry
BB
$4.78B
| $7.09M | ﹤0.01% |
1,880,502
-1,135,664
| -38% | -$5.17M |
|
3018
Frontline
FRO
$9.84B
| $7.09M | ﹤0.01% |
477,183
+186,654
| +64% | +$3.09M |
|
|
3019
Hormel Foods
HRL
$11.9B
| $7.08M | ﹤0.01% |
228,701
+41,220
| +22% | +$1.22M |
|
|
APLS
3020
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $7.07M | ﹤0.01% |
323,500
-535,700
| -62% | -$14.8M |
|
3021
Acadia Pharmaceuticals
ACAD
$5.02B
| $7.07M | ﹤0.01% |
425,470
-498,015
| -54% | -$9.05M |
|
3022
Old Dominion Freight Line
ODFL
$41.2B
| $7.06M | ﹤0.01% |
42,645
-52,823
| -55% | -$9.6M |
|
3023
Funko
FNKO
$398M
| $7.06M | ﹤0.01% |
1,028,487
+857,837
| +503% | +$9.97M |
|
3024
CALL
Haemonetics
HAE
$4.73B
| $7.05M | ﹤0.01% |
111,000
+21,800
| +24% | +$1.48M |
|
3025
Pentair
PNR
$9.84B
| $7.05M | ﹤0.01% |
80,616
+18,130
| +29% | +$1.73M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.